Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uncommon Pathological Types of Lung Cancer 1Prostatic Neoplasms 1Liver Neoplasms 1Liver Cirrhosis 1Endometrial Neoplasms 1Chemotherapy-induced Thrombocytopenia 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Hepatectomy 10Blood Specimen Collection 9Sorafenib 7Polymerase Chain Reaction 4Biopsy 4regorafenib 3Mass Spectrometry 3Liver Transplantation 3Immunohistochemistry 3Chemoembolization, Therapeutic 3Walking Speed 2Surveys and Questionnaires 2Psychiatric Rehabilitation 2Magnetic Resonance Imaging 2Gene Expression Profiling 2Bevacizumab 2trastuzumab deruxtecan 1taxane 1spartalizumab 1sintilimab 1lenvatinib 1gadolinium ethoxybenzyl DTPA 1donafenib 1carmofur 1camrelizumab 1cabozantinib 1atezolizumab 1apatinib 1anlotinib 1Yttrium-90 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Liver Neoplasms × Injections × Clear all
NCT04682847 2024-01-31

Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Unknown
40 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡